David Marchese in The New York Times:
It’s entirely possible, maybe even likely, that during some slow day at the lab early in her career, Jennifer Doudna, in a moment of private ambition, daydreamed about making a breakthrough that could change the world. But communicating with the world about the ethical ramifications of such a breakthrough? “Definitely not!” says Doudna, who along with Emmanuelle Charpentier won the Nobel Prize in Chemistry in 2020 for their research on CRISPR gene-editing technology. “I’m still on the learning curve with that.” Since 2012, when Doudna and her colleagues shared the findings of work they did on editing bacterial genes, the 58-year-old has become a leading voice in the conversation about how we might use CRISPR — uses that could, and probably will, include tweaking crops to become more drought resistant, curing genetically inheritable medical disorders and, most controversial, editing human embryos. “It’s a little scary, quite honestly,” Doudna says about the possibilities of our CRISPR future. “But it’s also quite exciting.”
More here.